SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sharps Compliance Corp. (SMED) 当前追踪市盈率 (P/E) 为 11.5. 追踪盈利收益率为 8.69%. PEG 0.03 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
- VALUE (100/100, 通过) — 市盈率低于市场平均水平 (11.5); PEG ≤ 1.0 — Peter Lynch 低估标准 (0.03); 盈利收益率超过债券收益率 (8.69%).
- PEG 比率 0.03 — 低于1.0表明股票相对于其盈利增长率被低估（Peter Lynch 标准）。
- 追踪盈利收益率 8.69% — 超过典型债券收益率（约4.3%），使股票相对固定收益更具吸引力。
SharesGrow 综合评分： 78/100 其中 4/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✓
健康
100/100
Debt-to-Equity & liquidity
→ Health
估值概览 — SMED
估值倍数
P/E (TTM)11.5
前瞻 P/EN/A
PEG 比率0.03
前瞻 PEGN/A
P/B 比率0.00
P/S 比率1.95
EV/EBITDA0.0
每股数据
EPS (TTM)$0.76
每股账面价值$0.00
每股营收$4.49
每股自由现金流$0.00
收益率与内在价值
盈利收益率8.69%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2012 |
$-0.24 |
$21.79M |
$-3.62M |
-16.6% |
| 2013 |
$-0.18 |
$21.53M |
$-2.71M |
-12.6% |
| 2014 |
$0.06 |
$26.57M |
$956K |
3.6% |
| 2015 |
$0.07 |
$30.9M |
$1.16M |
3.8% |
| 2016 |
$0.00 |
$33.38M |
$13K |
0% |
| 2017 |
$-0.08 |
$38.19M |
$-1.29M |
-3.4% |
| 2018 |
$-0.04 |
$40.14M |
$-672K |
-1.7% |
| 2019 |
$0.01 |
$44.31M |
$214K |
0.5% |
| 2020 |
$0.14 |
$51.15M |
$2.27M |
4.4% |
| 2021 |
$0.76 |
$76.42M |
$12.87M |
16.8% |
